QR kód

Impact of TSC2 loss on progression-free survival in uterine carcinosarcoma: A retrospective analysis

Objective: Uterine carcinosarcoma (UCS) is a rare and aggressive gynecological cancer with high recurrence rates and is associated with a poor prognosis. It is also characterized by a high frequency of copy number alterations (CNAs). This study aimed to determine which gene CNA contributes to progre...

Celý popis

Uloženo v:
Hlavní autoři: Ryoko Ichikawa, Tamotsu Sudo, Kyohei Takada, Akiko Ohwaki, Mayuko Ito, Yusuke Shimizu, Mayu Takeda, Eiji Sugihara, Tetsuya Takimoto, Haruki Nishizawa
Médium: Artigo
Jazyk:Inglês
Vydáno: Fujita Medical Society 2025-11-01
Edice:Fujita Medical Journal
Témata:
uterine carcinosarcoma
tsc2 loss
mtor inhibitor
On-line přístup:https://www.jstage.jst.go.jp/article/fmj/11/4/11_2025-001/_pdf/-char/en
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Podobné jednotky